_id
6917191d3c536f8df23164f8
Ticker
STRO
Name
Sutro Biopharma
Exchange
NASDAQ
Address
111 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.sutrobio.com
Description
Sutro Biopharma, Inc. operates as a oncology company. The company develops site-specific and novel-format antibody drug conjugates (ADCs) that enables its proprietary integrated cell-free protein synthesis platform, XpressCF; and site-specific conjugation platform, XpressCF+. Its lead product candidate includes STRO-004, a tissue factor (TF) targeting ADC for the treatment of TF-expressing solid tumors, including cervical, lung, and breast cancer. The company also develops VAX-24 and Vax-31 pneumococcal conjugate vaccine candidates that is in Phase II/III clinical trials for the treatment of invasive pneumococcal disease; and STRO-003, an ADC directed against an anti-receptor tyrosine kinase-like orphan receptor 1 (ROR1) for the treatment of solid tumors, such as triple negative breast cancer, non-small cell lung cancer, and ovarian cancer, as well as hematological cancers. Sutro Biopharma, Inc. has collaboration and license agreements with Vaxcyte to discover and develop vaccine candidates for the treatment or prophylaxis of infectious diseases; Tasly Biopharmaceuticals Co., Ltd. to develop and commercialize STRO-002 in Greater China; Ipsen to develop and commercialize STRO-003, an ADC targeting ROR1; and Astellas Pharma Inc. to develop immunostimulatory ADC. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.
Last Close
9.81
Volume
174632
Current Price
9.83
Change
0.20387359836900684
Last Updated
2025-12-04T13:40:28.447Z
Image
data:image/webp;base64,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
Ipo Date
2018-09-27T00:00:00.000Z
Market Cap
79090688
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9224
Sentiment Sources
5
Rating
3.7
Target Price
2.6857
Strong Buy
4
Buy
0
Hold
5
Sell
1
Strong Sell
0
Current Quarter
2025-09-30
Revenue
9693000
Cost Of Revenue
1900000
Gross Profit
9693000
Operating Expenses
58152000
Operating Income
-48459000
Interest Expense
10407000
Pretax Income
-56857000
Net Income
-56857000
Eps
-6.6993158702040985
Dividends Per Share
-
Shares Outstanding
85135290
Income Tax Expense
-
EBITDA
-44550000
Operating Margin
-499.93809965954813
Total Other Income Expense Net
-8398000
Cash
65927000
Short Term Investments
101667000
Receivables
3922000
Inventories
-
Total Current Assets
182113000
Property Plant Equipment
26687000
Total Assets
209658000
Payables
7034000
Short Term Debt
7960000
Long Term Debt
-
Total Liabilities
296926000
Equity
-87268000
Depreciation
1900000
Change In Working Capital
4649000
Cash From Operations
-38189000
Capital Expenditures
251000
Cash From Investing
39989000
Cash From Financing
102000
Net Change In Cash
1902000
PE
-
PB
-0.9559869869826282
ROE
65.15217490947425
ROA
-27.11892701447119
FCF
-38440000
Fcf Percent
-3.965748478283297
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
2
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
6.3
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
5
Net Net Investing Score
1.5
Quality Investing Score
2.5
Value Investing Score
2.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
9693000
Quarters > 0 > income Statement > cost Of Revenue
1900000
Quarters > 0 > income Statement > gross Profit
9693000
Quarters > 0 > income Statement > operating Expenses
58152000
Quarters > 0 > income Statement > operating Income
-48459000
Quarters > 0 > income Statement > interest Expense
10407000
Quarters > 0 > income Statement > pretax Income
-56857000
Quarters > 0 > income Statement > net Income
-56857000
Quarters > 0 > income Statement > eps
-6.6993158702040985
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
8486986
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-44550000
Quarters > 0 > income Statement > operating Margin
-499.93809965954813
Quarters > 0 > income Statement > total Other Income Expense Net
-8398000
Quarters > 0 > balance Sheet > cash
65927000
Quarters > 0 > balance Sheet > short Term Investments
101667000
Quarters > 0 > balance Sheet > receivables
3922000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
182113000
Quarters > 0 > balance Sheet > property Plant Equipment
26687000
Quarters > 0 > balance Sheet > total Assets
209658000
Quarters > 0 > balance Sheet > payables
7034000
Quarters > 0 > balance Sheet > short Term Debt
7960000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
296926000
Quarters > 0 > balance Sheet > equity
-87268000
Quarters > 0 > cash Flow > net Income
-56857000
Quarters > 0 > cash Flow > depreciation
1900000
Quarters > 0 > cash Flow > change In Working Capital
4649000
Quarters > 0 > cash Flow > cash From Operations
-38189000
Quarters > 0 > cash Flow > capital Expenditures
251000
Quarters > 0 > cash Flow > cash From Investing
39989000
Quarters > 0 > cash Flow > cash From Financing
102000
Quarters > 0 > cash Flow > net Change In Cash
1902000
Quarters > 0 > ratios > PE
-6.6993158702040985
Quarters > 0 > ratios > PB
-0.9559869869826282
Quarters > 0 > ratios > ROE
65.15217490947425
Quarters > 0 > ratios > ROA
-27.11892701447119
Quarters > 0 > ratios > FCF
-38440000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-3.965748478283297
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
63745000
Quarters > 1 > income Statement > cost Of Revenue
1900000
Quarters > 1 > income Statement > gross Profit
63745000
Quarters > 1 > income Statement > operating Expenses
67090000
Quarters > 1 > income Statement > operating Income
-3345000
Quarters > 1 > income Statement > interest Expense
9647000
Quarters > 1 > income Statement > pretax Income
-11517000
Quarters > 1 > income Statement > net Income
-11499000
Quarters > 1 > income Statement > eps
-1.3595391730894715
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
8458013
Quarters > 1 > income Statement > income Tax Expense
-18000
Quarters > 1 > income Statement > EBITDA
1074000
Quarters > 1 > income Statement > operating Margin
-5.247470389834497
Quarters > 1 > income Statement > total Other Income Expense Net
-8172000
Quarters > 1 > balance Sheet > cash
64025000
Quarters > 1 > balance Sheet > short Term Investments
141106000
Quarters > 1 > balance Sheet > receivables
7999000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
231630000
Quarters > 1 > balance Sheet > property Plant Equipment
29817000
Quarters > 1 > balance Sheet > total Assets
262355000
Quarters > 1 > balance Sheet > payables
4308000
Quarters > 1 > balance Sheet > short Term Debt
8057000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
294466000
Quarters > 1 > balance Sheet > equity
-32111000
Quarters > 1 > cash Flow > net Income
-11499000
Quarters > 1 > cash Flow > depreciation
1900000
Quarters > 1 > cash Flow > change In Working Capital
-50581000
Quarters > 1 > cash Flow > cash From Operations
-44724000
Quarters > 1 > cash Flow > capital Expenditures
86000
Quarters > 1 > cash Flow > cash From Investing
2580000
Quarters > 1 > cash Flow > cash From Financing
-60000
Quarters > 1 > cash Flow > net Change In Cash
-42204000
Quarters > 1 > ratios > PE
-1.3595391730894715
Quarters > 1 > ratios > PB
-2.589214530534708
Quarters > 1 > ratios > ROE
35.810158512659214
Quarters > 1 > ratios > ROA
-4.382992510148463
Quarters > 1 > ratios > FCF
-44810000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-0.7029570946740921
Quarters > 1 > health Score
30
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
17399000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
17399000
Quarters > 2 > income Statement > operating Expenses
85913000
Quarters > 2 > income Statement > operating Income
-68514000
Quarters > 2 > income Statement > interest Expense
10643000
Quarters > 2 > income Statement > pretax Income
-75968000
Quarters > 2 > income Statement > net Income
-75968000
Quarters > 2 > income Statement > eps
-9.141095812444853
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
8310601
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-45571000
Quarters > 2 > income Statement > operating Margin
-393.78125179608026
Quarters > 2 > income Statement > total Other Income Expense Net
-7454000
Quarters > 2 > balance Sheet > cash
106229000
Quarters > 2 > balance Sheet > short Term Investments
142743000
Quarters > 2 > balance Sheet > receivables
13562000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
287409000
Quarters > 2 > balance Sheet > property Plant Equipment
33078000
Quarters > 2 > balance Sheet > total Assets
321430000
Quarters > 2 > balance Sheet > payables
8180000
Quarters > 2 > balance Sheet > short Term Debt
7765000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
347241000
Quarters > 2 > balance Sheet > equity
-25811000
Quarters > 2 > cash Flow > net Income
-75968000
Quarters > 2 > cash Flow > depreciation
1900000
Quarters > 2 > cash Flow > change In Working Capital
-9146000
Quarters > 2 > cash Flow > cash From Operations
-67883000
Quarters > 2 > cash Flow > capital Expenditures
1174000
Quarters > 2 > cash Flow > cash From Investing
-16258000
Quarters > 2 > cash Flow > cash From Financing
66000
Quarters > 2 > cash Flow > net Change In Cash
-84075000
Quarters > 2 > ratios > PE
-9.141095812444853
Quarters > 2 > ratios > PB
-3.1650539626515823
Quarters > 2 > ratios > ROE
294.32412537290304
Quarters > 2 > ratios > ROA
-23.634383847182903
Quarters > 2 > ratios > FCF
-69057000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-3.969021208115409
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
14809000
Quarters > 3 > income Statement > cost Of Revenue
-1738000
Quarters > 3 > income Statement > gross Profit
14809000
Quarters > 3 > income Statement > operating Expenses
80067000
Quarters > 3 > income Statement > operating Income
-65258000
Quarters > 3 > income Statement > interest Expense
8690000
Quarters > 3 > income Statement > pretax Income
-70088000
Quarters > 3 > income Statement > net Income
-72443000
Quarters > 3 > income Statement > eps
-8.778157494514181
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
8252643
Quarters > 3 > income Statement > income Tax Expense
2355000
Quarters > 3 > income Statement > EBITDA
-59530000
Quarters > 3 > income Statement > operating Margin
-440.66446080086433
Quarters > 3 > income Statement > total Other Income Expense Net
-4830000
Quarters > 3 > balance Sheet > cash
190304000
Quarters > 3 > balance Sheet > short Term Investments
126591000
Quarters > 3 > balance Sheet > receivables
8616000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
343310000
Quarters > 3 > balance Sheet > property Plant Equipment
35867000
Quarters > 3 > balance Sheet > total Assets
387207000
Quarters > 3 > balance Sheet > payables
10475000
Quarters > 3 > balance Sheet > short Term Debt
7480000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
342606000
Quarters > 3 > balance Sheet > equity
44601000
Quarters > 3 > cash Flow > net Income
-72443000
Quarters > 3 > cash Flow > depreciation
1868000
Quarters > 3 > cash Flow > change In Working Capital
-15735000
Quarters > 3 > cash Flow > cash From Operations
-71738000
Quarters > 3 > cash Flow > capital Expenditures
1068000
Quarters > 3 > cash Flow > cash From Investing
87488000
Quarters > 3 > cash Flow > cash From Financing
-24000
Quarters > 3 > cash Flow > net Change In Cash
15726000
Quarters > 3 > ratios > PE
-8.778157494514181
Quarters > 3 > ratios > PB
1.818871341225533
Quarters > 3 > ratios > ROE
-162.4246093136925
Quarters > 3 > ratios > ROA
-18.70911424638501
Quarters > 3 > ratios > FCF
-72806000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-4.916334661354582
Quarters > 3 > health Score
17
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
62043000
Annuals > 0 > income Statement > cost Of Revenue
7218000
Annuals > 0 > income Statement > gross Profit
54825000
Annuals > 0 > income Statement > operating Expenses
293278000
Annuals > 0 > income Statement > operating Income
-238453000
Annuals > 0 > income Statement > interest Expense
31070000
Annuals > 0 > income Statement > pretax Income
-225098000
Annuals > 0 > income Statement > net Income
-227461000
Annuals > 0 > income Statement > eps
-29.606061237133797
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
7682920
Annuals > 0 > income Statement > income Tax Expense
2363000
Annuals > 0 > income Statement > EBITDA
-180453000
Annuals > 0 > income Statement > operating Margin
-384.3350579436842
Annuals > 0 > income Statement > total Other Income Expense Net
13355000
Annuals > 0 > balance Sheet > cash
190304000
Annuals > 0 > balance Sheet > short Term Investments
126591000
Annuals > 0 > balance Sheet > receivables
8616000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
343310000
Annuals > 0 > balance Sheet > property Plant Equipment
35867000
Annuals > 0 > balance Sheet > total Assets
387207000
Annuals > 0 > balance Sheet > payables
10475000
Annuals > 0 > balance Sheet > short Term Debt
7480000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
342606000
Annuals > 0 > balance Sheet > equity
44601000
Annuals > 0 > cash Flow > net Income
-227461000
Annuals > 0 > cash Flow > depreciation
7218000
Annuals > 0 > cash Flow > change In Working Capital
8900000
Annuals > 0 > cash Flow > cash From Operations
-191540000
Annuals > 0 > cash Flow > capital Expenditures
3098000
Annuals > 0 > cash Flow > cash From Investing
218508000
Annuals > 0 > cash Flow > cash From Financing
94054000
Annuals > 0 > cash Flow > net Change In Cash
121022000
Annuals > 0 > ratios > PE
-29.606061237133797
Annuals > 0 > ratios > PB
1.4986525862648816
Annuals > 0 > ratios > ROE
-509.9908073810004
Annuals > 0 > ratios > ROA
-58.74403097051448
Annuals > 0 > ratios > FCF
-194638000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-3.1371468175297776
Annuals > 0 > health Score
16
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
153731000
Annuals > 1 > income Statement > cost Of Revenue
6816000
Annuals > 1 > income Statement > gross Profit
146915000
Annuals > 1 > income Statement > operating Expenses
236193000
Annuals > 1 > income Statement > operating Income
-89278000
Annuals > 1 > income Statement > interest Expense
23750000
Annuals > 1 > income Statement > pretax Income
-88601000
Annuals > 1 > income Statement > net Income
-106793000
Annuals > 1 > income Statement > eps
-17.75045151930887
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
6016354
Annuals > 1 > income Statement > income Tax Expense
18192000
Annuals > 1 > income Statement > EBITDA
-67915000
Annuals > 1 > income Statement > operating Margin
-58.07416851513357
Annuals > 1 > income Statement > total Other Income Expense Net
677000
Annuals > 1 > balance Sheet > cash
69268000
Annuals > 1 > balance Sheet > short Term Investments
306350000
Annuals > 1 > balance Sheet > receivables
36078000
Annuals > 1 > balance Sheet > inventories
1
Annuals > 1 > balance Sheet > total Current Assets
421542000
Annuals > 1 > balance Sheet > property Plant Equipment
44755000
Annuals > 1 > balance Sheet > total Assets
470736000
Annuals > 1 > balance Sheet > payables
9440000
Annuals > 1 > balance Sheet > short Term Debt
10481000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
321087000
Annuals > 1 > balance Sheet > equity
149649000
Annuals > 1 > cash Flow > net Income
-106793000
Annuals > 1 > cash Flow > depreciation
6816000
Annuals > 1 > cash Flow > change In Working Capital
-34375000
Annuals > 1 > cash Flow > cash From Operations
-111616000
Annuals > 1 > cash Flow > capital Expenditures
4315000
Annuals > 1 > cash Flow > cash From Investing
-3924000
Annuals > 1 > cash Flow > cash From Financing
137554000
Annuals > 1 > cash Flow > net Change In Cash
22014000
Annuals > 1 > ratios > PE
-17.75045151930887
Annuals > 1 > ratios > PB
0.3497669867489926
Annuals > 1 > ratios > ROE
-71.3623211648591
Annuals > 1 > ratios > ROA
-22.686388973862208
Annuals > 1 > ratios > FCF
-115931000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-0.754115955792911
Annuals > 1 > health Score
20
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
67772000
Annuals > 2 > income Statement > cost Of Revenue
8288000
Annuals > 2 > income Statement > gross Profit
59484000
Annuals > 2 > income Statement > operating Expenses
188427000
Annuals > 2 > income Statement > operating Income
-128943000
Annuals > 2 > income Statement > interest Expense
3346000
Annuals > 2 > income Statement > pretax Income
-116704000
Annuals > 2 > income Statement > net Income
-119204000
Annuals > 2 > income Statement > eps
-23.493477132764635
Annuals > 2 > income Statement > dividends Per Share
463000
Annuals > 2 > income Statement > shares Outstanding
5073919
Annuals > 2 > income Statement > income Tax Expense
2500000
Annuals > 2 > income Statement > EBITDA
-105070000
Annuals > 2 > income Statement > operating Margin
-190.25998937614355
Annuals > 2 > income Statement > total Other Income Expense Net
12239000
Annuals > 2 > balance Sheet > cash
47254000
Annuals > 2 > balance Sheet > short Term Investments
287110000
Annuals > 2 > balance Sheet > receivables
7122000
Annuals > 2 > balance Sheet > inventories
-11667000
Annuals > 2 > balance Sheet > total Current Assets
353153000
Annuals > 2 > balance Sheet > property Plant Equipment
51064000
Annuals > 2 > balance Sheet > total Assets
406944000
Annuals > 2 > balance Sheet > payables
4797000
Annuals > 2 > balance Sheet > short Term Debt
21670000
Annuals > 2 > balance Sheet > long Term Debt
3771000
Annuals > 2 > balance Sheet > total Liabilities
189896000
Annuals > 2 > balance Sheet > equity
217048000
Annuals > 2 > cash Flow > net Income
-119204000
Annuals > 2 > cash Flow > depreciation
5690000
Annuals > 2 > cash Flow > change In Working Capital
104405000
Annuals > 2 > cash Flow > cash From Operations
3549000
Annuals > 2 > cash Flow > capital Expenditures
7858000
Annuals > 2 > cash Flow > cash From Investing
-35022000
Annuals > 2 > cash Flow > cash From Financing
48313000
Annuals > 2 > cash Flow > net Change In Cash
16840000
Annuals > 2 > ratios > PE
-23.493477132764635
Annuals > 2 > ratios > PB
0.20337941515240868
Annuals > 2 > ratios > ROE
-54.92057056503631
Annuals > 2 > ratios > ROA
-29.292482503735158
Annuals > 2 > ratios > FCF
-4309000
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
-0.06358082984123237
Annuals > 2 > health Score
31
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
61880000
Annuals > 3 > income Statement > cost Of Revenue
9773000
Annuals > 3 > income Statement > gross Profit
52107000
Annuals > 3 > income Statement > operating Expenses
150631000
Annuals > 3 > income Statement > operating Income
-98524000
Annuals > 3 > income Statement > interest Expense
3137000
Annuals > 3 > income Statement > pretax Income
-105538000
Annuals > 3 > income Statement > net Income
-105538000
Annuals > 3 > income Statement > eps
-22.883799311738372
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
4611909
Annuals > 3 > income Statement > income Tax Expense
3137000
Annuals > 3 > income Statement > EBITDA
-97557000
Annuals > 3 > income Statement > operating Margin
-159.21784098254685
Annuals > 3 > income Statement > total Other Income Expense Net
-7014000
Annuals > 3 > balance Sheet > cash
30414000
Annuals > 3 > balance Sheet > short Term Investments
167524000
Annuals > 3 > balance Sheet > receivables
12454000
Annuals > 3 > balance Sheet > inventories
1
Annuals > 3 > balance Sheet > total Current Assets
218515000
Annuals > 3 > balance Sheet > property Plant Equipment
51591000
Annuals > 3 > balance Sheet > total Assets
341408000
Annuals > 3 > balance Sheet > payables
6009000
Annuals > 3 > balance Sheet > short Term Debt
10412000
Annuals > 3 > balance Sheet > long Term Debt
15738000
Annuals > 3 > balance Sheet > total Liabilities
88844000
Annuals > 3 > balance Sheet > equity
252564000
Annuals > 3 > cash Flow > net Income
-105538000
Annuals > 3 > cash Flow > depreciation
4844000
Annuals > 3 > cash Flow > change In Working Capital
-17620000
Annuals > 3 > cash Flow > cash From Operations
-81679000
Annuals > 3 > cash Flow > capital Expenditures
15323000
Annuals > 3 > cash Flow > cash From Investing
-97315000
Annuals > 3 > cash Flow > cash From Financing
3256000
Annuals > 3 > cash Flow > net Change In Cash
-175738000
Annuals > 3 > ratios > PE
-22.883799311738372
Annuals > 3 > ratios > PB
0.15886511260512184
Annuals > 3 > ratios > ROE
-41.78663625853249
Annuals > 3 > ratios > ROA
-30.91257381197863
Annuals > 3 > ratios > FCF
-97002000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-1.5675824175824176
Annuals > 3 > health Score
34
Valuation > metrics > PE
-6.6993158702040985
Valuation > metrics > PB
-0.9559869869826282
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
65.15217490947425
Profitability > metrics > ROA
-31.220725593450222
Profitability > metrics > Net Margin
-5.865779428453523
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-4.656385125396368
Risk > final Score
11
Risk > verdict
High
Liquidity > metrics > Current Ratio
12.145724956649326
Liquidity > metrics > Quick Ratio
12.145724956649326
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
80
Prev Profitabilities > 0
40
Prev Profitabilities > 1
40
Prev Profitabilities > 2
0
Prev Risks > 0
29
Prev Risks > 1
4
Prev Risks > 2
-24
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T01:15:15.912Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-05
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.5573
Earnings History > 0 > eps Estimate
-0.4183
Earnings History > 0 > eps Difference
-0.139
Earnings History > 0 > surprise Percent
-33.2297
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-07
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.14
Earnings History > 1 > eps Estimate
-0.41
Earnings History > 1 > eps Difference
0.27
Earnings History > 1 > surprise Percent
65.8537
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-12
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.91
Earnings History > 2 > eps Estimate
-0.92
Earnings History > 2 > eps Difference
0.01
Earnings History > 2 > surprise Percent
1.087
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-24
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.6332
Earnings History > 3 > eps Estimate
-0.955
Earnings History > 3 > eps Difference
0.3218
Earnings History > 3 > surprise Percent
33.6963
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-11
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.4982
Earnings History > 4 > eps Estimate
-0.73
Earnings History > 4 > eps Difference
0.2318
Earnings History > 4 > surprise Percent
31.7534
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-13
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.59
Earnings History > 5 > eps Estimate
-0.79
Earnings History > 5 > eps Difference
0.2
Earnings History > 5 > surprise Percent
25.3165
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-13
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.95
Earnings History > 6 > eps Estimate
-0.92
Earnings History > 6 > eps Difference
-0.03
Earnings History > 6 > surprise Percent
-3.2609
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-25
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
0.52
Earnings History > 7 > eps Estimate
-0.82
Earnings History > 7 > eps Difference
1.34
Earnings History > 7 > surprise Percent
163.4146
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-13
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.81
Earnings History > 8 > eps Estimate
-0.74
Earnings History > 8 > eps Difference
-0.07
Earnings History > 8 > surprise Percent
-9.4595
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-10
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.64
Earnings History > 9 > eps Estimate
-0.73
Earnings History > 9 > eps Difference
0.09
Earnings History > 9 > surprise Percent
12.3288
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-15
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.85
Earnings History > 10 > eps Estimate
-0.81
Earnings History > 10 > eps Difference
-0.04
Earnings History > 10 > surprise Percent
-4.9383
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-30
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.68
Earnings History > 11 > eps Estimate
-0.62
Earnings History > 11 > eps Difference
-0.06
Earnings History > 11 > surprise Percent
-9.6774
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-08
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.37
Earnings History > 12 > eps Estimate
-0.74
Earnings History > 12 > eps Difference
0.37
Earnings History > 12 > surprise Percent
50
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-08
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.55
Earnings History > 13 > eps Estimate
-0.46
Earnings History > 13 > eps Difference
-0.09
Earnings History > 13 > surprise Percent
-19.5652
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-09
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.84
Earnings History > 14 > eps Estimate
-0.76
Earnings History > 14 > eps Difference
-0.08
Earnings History > 14 > surprise Percent
-10.5263
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-02-28
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.83
Earnings History > 15 > eps Estimate
-0.69
Earnings History > 15 > eps Difference
-0.14
Earnings History > 15 > surprise Percent
-20.2899
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-10
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.67
Earnings History > 16 > eps Estimate
-0.65
Earnings History > 16 > eps Difference
-0.02
Earnings History > 16 > surprise Percent
-3.0769
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-09
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.13
Earnings History > 17 > eps Estimate
-0.41
Earnings History > 17 > eps Difference
0.28
Earnings History > 17 > surprise Percent
68.2927
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-07
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.66
Earnings History > 18 > eps Estimate
-0.6
Earnings History > 18 > eps Difference
-0.06
Earnings History > 18 > surprise Percent
-10
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-18
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-1.48
Earnings History > 19 > eps Estimate
-0.57
Earnings History > 19 > eps Difference
-0.91
Earnings History > 19 > surprise Percent
-159.6491
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-05
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
0.45
Earnings History > 20 > eps Estimate
-0.51
Earnings History > 20 > eps Difference
0.96
Earnings History > 20 > surprise Percent
188.2353
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-06
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.59
Earnings History > 21 > eps Estimate
-0.64
Earnings History > 21 > eps Difference
0.05
Earnings History > 21 > surprise Percent
7.8125
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-11
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.84
Earnings History > 22 > eps Estimate
-0.69
Earnings History > 22 > eps Difference
-0.15
Earnings History > 22 > surprise Percent
-21.7391
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-16
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
BeforeMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.64
Earnings History > 23 > eps Estimate
-0.69
Earnings History > 23 > eps Difference
0.05
Earnings History > 23 > surprise Percent
7.2464
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-11-08
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
BeforeMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.56
Earnings History > 24 > eps Estimate
-0.65
Earnings History > 24 > eps Difference
0.09
Earnings History > 24 > surprise Percent
13.8462
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-14
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
BeforeMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.6
Earnings History > 25 > eps Estimate
-0.68
Earnings History > 25 > eps Difference
0.08
Earnings History > 25 > surprise Percent
11.7647
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-05-16
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
BeforeMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.62
Earnings History > 26 > eps Estimate
-0.63
Earnings History > 26 > eps Difference
0.01
Earnings History > 26 > surprise Percent
1.5873
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2018-12-31
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.26
Earnings History > 27 > eps Estimate
-0.63
Earnings History > 27 > eps Difference
0.37
Earnings History > 27 > surprise Percent
58.7302
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-11-14
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
AfterMarket
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-21.26
Earnings History > 28 > eps Estimate
-0.16
Earnings History > 28 > eps Difference
-21.1
Earnings History > 28 > surprise Percent
-13187.5
Earnings History > 29 > period
2018-06-30
Earnings History > 29 > report Date
2018-09-26
Earnings History > 29 > date
2018-06-30
Earnings History > 29 > before After Market
AfterMarket
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-1.37
Earnings History > 29 > eps Estimate
0
Earnings History > 29 > eps Difference
-1.37
Earnings History > 29 > surprise Percent
-
Sutro Biopharma, Inc. operates as a oncology company. The company develops site-specific and novel-format antibody drug conjugates (ADCs) that enables its proprietary integrated cell-free protein synthesis platform, XpressCF; and site-specific conjugation platform, XpressCF+. Its lead product candidate includes STRO-004, a tissue factor (TF) targeting ADC for the treatment of TF-expressing solid tumors, including cervical, lung, and breast cancer. The company also develops VAX-24 and Vax-31 pneumococcal conjugate vaccine candidates that is in Phase II/III clinical trials for the treatment of invasive pneumococcal disease; and STRO-003, an ADC directed against an anti-receptor tyrosine kinase-like orphan receptor 1 (ROR1) for the treatment of solid tumors, such as triple negative breast cancer, non-small cell lung cancer, and ovarian cancer, as well as hematological cancers. Sutro Biopharma, Inc. has collaboration and license agreements with Vaxcyte to discover and develop vaccine candidates for the treatment or prophylaxis of infectious diseases; Tasly Biopharmaceuticals Co., Ltd. to develop and commercialize STRO-002 in Greater China; Ipsen to develop and commercialize STRO-003, an ADC targeting ROR1; and Astellas Pharma Inc. to develop immunostimulatory ADC. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ARBF Capital LLC Purchases New Position in Sutro Biopharma, Inc. $STRO MarketBeat
Read more →Velan Capital Investment Management LP Acquires 2,030,000 Shares of Sutro Biopharma, Inc. $STRO MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$2.6857
Analyst Picks
Strong Buy
4
Buy
0
Hold
5
Sell
1
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 63.44% of the total shares of Sutro Biopharma
1.
Suvretta Capital Management, LLC(7.6537%)
since
2025/06/30
2.
Kynam Capital Management, LP(6.0019%)
since
2025/06/30
3.
Millennium Management LLC(5.5822%)
since
2025/06/30
4.
Vanguard Group Inc(4.8544%)
since
2025/06/30
5.
Velan Capital Investment Management LP(3.6096%)
since
2025/06/30
6.
Merck & Co Inc(3.2127%)
since
2025/06/30
7.
Vestal Point Capital LP(3.067%)
since
2025/06/30
8.
TANG CAPITAL MANAGEMENT LLC(3.0217%)
since
2025/06/30
9.
Vanguard Total Stock Mkt Idx Inv(2.7885%)
since
2025/07/31
10.
Eversept Partners, LLC(2.704%)
since
2025/06/30
11.
Samsara BioCapital, LLC(2.5914%)
since
2025/06/30
12.
BlackRock Inc(2.4854%)
since
2025/06/30
13.
Adage Capital Partners Gp LLC(2.3592%)
since
2025/06/30
14.
UBS Group AG(1.9096%)
since
2025/06/30
15.
AQR Capital Management LLC(1.1946%)
since
2025/06/30
16.
Renaissance Technologies Corp(1.0772%)
since
2025/06/30
17.
Geode Capital Management, LLC(0.9636%)
since
2025/06/30
18.
Vanguard Institutional Extnd Mkt Idx Tr(0.9618%)
since
2025/07/31
19.
Affinity Asset Advisors, LLC(0.8879%)
since
2025/06/30
20.
Jane Street Group LLC(0.8126%)
since
2025/06/30
21.
Dimensional Fund Advisors, Inc.(0.7413%)
since
2025/06/30
22.
Goldman Sachs Small Cp Val Insghts Instl(0.5516%)
since
2025/04/30
23.
iShares Biotechnology ETF(0.5509%)
since
2025/08/31
24.
Dafna Capital Management LLC(0.5156%)
since
2025/06/30
25.
Fidelity Extended Market Index(0.4827%)
since
2025/07/31
26.
Vanguard US Value Factor ETF(0.465%)
since
2025/06/30
27.
Fisher US Small Cap Opportunities(0.4163%)
since
2025/06/30
28.
Goldman Sachs Small Cap Eq Insghts Instl(0.2992%)
since
2025/04/30
29.
DFA US Small Cap I(0.226%)
since
2025/07/31
30.
iShares Micro-Cap ETF(0.208%)
since
2025/08/31
31.
Extended Equity Market Fund K(0.19%)
since
2025/06/30
32.
Fidelity Total Market Index(0.1596%)
since
2025/07/31
33.
Dimensional US Small Cap ETF(0.151%)
since
2025/08/29
34.
Fidelity Series Total Market Index(0.1275%)
since
2025/07/31
35.
Invesco RAFI US 1500 Small-Mid ETF(0.1153%)
since
2025/08/29
36.
Spartan Extended Market Index Pool F(0.1105%)
since
2025/07/31
37.
NT Col R2000 Val Idx Fd -DC -L -TierFour(0.1082%)
since
2025/03/31
38.
Northern Trust Extended Eq Market Idx(0.1015%)
since
2025/06/30
39.
NT Ext Equity Mkt Idx Fd - L(0.1015%)
since
2025/06/30
40.
abrdn Healthcare Investors(0.0819%)
since
2025/08/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.5573
EPS Estimate
-0.4183
EPS Difference
-0.139
Surprise Percent
-33.2297%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.